From Navartis quarterly:
Pluvicto (USD 345 million, +44% cc) grew in the US and Europe. With supply now unconstrained, the focus is on increasing share in established RLT sites, opening new sites and referral pathways, and initiating new patients.
USD$655 mill for the half.
From Navartis quarterly:Pluvicto (USD 345 million, +44% cc) grew...
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.32 |
Change
0.100(0.52%) |
Mkt cap ! $6.465B | |||
| Open | High | Low | Value | Volume |
| $19.30 | $19.50 | $19.08 | $22.36M | 1.160M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3890 | $19.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.34 | 100 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| TLX (ASX) Chart |